The Antipsychotic Drug Market to 2024

Transcription

1 The Antipsychotic Drug Market to 2024 Products, Therapeutics Markets & Forecasts Report Brochure

2 Greystone Research Associates is pleased to announce the publication of a new market assessment. Antipsychotics Drug Market to 2024: Products, Therapeutics, Markets, Players and Forecasts is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, indications, and commercial opportunities for antipsychotic drugs. Provider organization business managers, healthcare administrators and investors will also benefit from this study.. A Complex and Evolving Market Antipsychotic medications have been available since the mid-1950s. They have greatly improved the outlook for individual patients. These medications reduce the psychotic symptoms of schizophrenia and usually allow the patient to function more effectively and appropriately. Antipsychotic drugs are the best treatment now available, but they do not cure schizophrenia or ensure that there will be no further psychotic episodes. The choice and dosage of medication can be made only by a qualified physician who is well trained in the medical treatment of mental disorders. The dosage of medication is individualized for each patient, since people may vary a great deal in the amount of drug needed to reduce symptoms without producing troublesome side effects. This report examines this evolving market as the incidence of psychotic patients continues to grow and regulatory markets re-examine the legacy protocols for treatment.

3 T a b l e o f C o n t e n t s Executive Summary Drug Therapeutics Devices and Formulations Market Segments and Indications Competing Technologies Established Therapeutic Targets Demographics and Growth Market Drivers Risk Factors Product Assessment & Analysis Aripiprazole Asenapine Fluphenazine Haloperidol Iloperidone Loxapine Olanzapine Paliperidone Quetiapine Fumarate Risperidone Ziprasidone Other Antipsychotics Lurasidone Perphenazine Thioridazine Thiothixene Trifluoperazine Trihexyphenidyl Antipsychotics Competitive Landscape Dosage Dosage Form Patents Exclusivity P(iv) Filings Product Development Clinical Trials Markets Market Segment Analysis Regions Market Data Forecasts Product Forecasts Market Forecasts Market Share Forecasts Market Factors Regulatory Issues Device Branding Patient Compliance and Ease of Use Healthcare Economics Company Profile

4 Comprehensive Assessments & Forecasts Comprehensive Drug Product Dosage Maps by Supplier

5 As-Supplied Market Share by Product and Supplier

6 IP and Drug Brand Status including Patent and Exclusivity Data

7 Funding and Sponsor Relationships for all Currently Open Clinical Trials

8 Activity Maps and Heat Diagrams Provide Market Insight

9 Comprehensive Market Data and Forecasts

10 Market Data that Quantifies Key Strategic Factors

11 Report Format and Availability This report is available electronic format. A site license for a single physical location and a corporate license are also available. Custom licensing options to address specific company user requirements are available by calling client services at , or by ing clientservices@greystoneassociates.org. Methodology Research methodology is based on primary research in the form of in-depth interviews with key market participants, technology developers, distributors, industry experts, and market influencers, a list that includes regulatory officials, industry trade groups, and materials standards organizations. Primary data is evaluated and normalized against secondary sources including trade journal articles, technical literature, industry publications, company data sheets and published information, and statistical data from government agencies and trade associations. Forecasts and projections of market demand and future market activity are derived using standard modeling and statistical techniques. About Greystone Associates Greystone Associates is a medical technology consulting firm focused on the areas of medical market strategy, product commercialization, venture development, and market research. We assist medical and healthcare market participants in achieving their business objectives through the creation of detailed development strategies, product commercialization programs, and comprehensive market and technology research and analysis. Our market research publications are designed, researched and written to provide timely and insightful information and data on focused market segments, with the aim of providing market participants with the essential knowledge to refine and execute their marketing plans and financial targets.

12 How To Order Orders may be placed via postal mail, or fax. Orders not accompanied by a purchase order must contain a telephone number for verification, and clearly indicate the physical shipping address and billing address. Payment We accept the following forms of payment: Company Check: Please make checks payable to Greystone Associates Credit Cards: We accept MasterCard, Visa and American Express Wire Transfers: See Wire Transfers below for more information Fax to: or to research@greystoneassociates.org The Antipsychotic Drug Market to 2024 Select Format License Price (U.S. Funds) Total PDF Single User License $1, PDF Site License $3, PDF Corporate License $5, Total Payment (U.S. funds) Method of Payment: Wire Transfer (International) Card Number: Name on Card Expiration Date: Card CVV Signature - Billing Information Name: Title: Company: Street Address: City,State/Province: Country/Postal Code: Phone: Fax: Shipping Information Click here if same as Billing Information Name: Title: Company: Street Address: City,State/Province: Country/Postal Code: Phone: Fax: